Related Experiment Video
Updated: Aug 18, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Inhibition of Mycoplasma pneumoniae by actinomycin D
Abstract:
Growth of Mycoplasma pneumoniae was completely prevented by 0.06 mug of actinomycin D/ml, and 0.00375 mug/ml caused 90% inhibition. It thus appears that M. pneumoniae is more susceptible to actinomycin D than previously reported. Low concentrations (0.019 mug/ml) of the antibiotic primarily inhibited ribonucleic acid synthesis and high concentrations (20 mug/ml) inhibited both ribonucleic and deoxyribonucleic acid synthesis.
Insights
Mycoplasma pneumoniae growth is highly sensitive to actinomycin D, with low concentrations inhibiting RNA synthesis and high concentrations affecting both RNA and DNA synthesis. This suggests M. pneumoniae is more susceptible to this antibiotic than previously understood.
Area of Science:
- Microbiology
- Molecular Biology
- Pharmacology
Background:
- Mycoplasma pneumoniae is a significant human pathogen.
- Actinomycin D is an antibiotic known to inhibit nucleic acid synthesis.
Purpose of the Study:
- To investigate the susceptibility of Mycoplasma pneumoniae to actinomycin D.
- To determine the effects of different actinomycin D concentrations on M. pneumoniae nucleic acid synthesis.
Main Methods:
- Exposure of M. pneumoniae cultures to varying concentrations of actinomycin D.
- Quantification of M. pneumoniae growth inhibition.
- Measurement of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) synthesis.
Main Results:
- Complete growth inhibition of M. pneumoniae occurred at 0.06 µg/ml of actinomycin D.
- 90% growth inhibition was observed at 0.00375 µg/ml of actinomycin D.
- Low actinomycin D concentrations (0.019 µg/ml) primarily inhibited RNA synthesis, while high concentrations (20 µg/ml) inhibited both RNA and DNA synthesis.
Conclusions:
- Mycoplasma pneumoniae exhibits greater susceptibility to actinomycin D than previously reported.
- Actinomycin D's mechanism of action on M. pneumoniae involves inhibition of nucleic acid synthesis, with concentration-dependent effects on RNA and DNA.
Related Concept Videos
Bacterial Phylum Actinobacteria
Atypical Pneumonia
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance

